Clinical Trial Update: Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing colesevelam to placebo in nonalcoholic steatohepatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

Sponsor: University of California, San Diego | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-21